{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:46:15Z","timestamp":1788281175253,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2018.12.020","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:03:14Z","timestamp":1547006594000},"page":"1065-1069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Sree","family":"Harsha Varma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Tirupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.V.S.","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Sarathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.12.020_bib1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.dsx.2018.12.020_bib2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.12.020_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.dsx.2018.12.020_bib4","first-page":"25","article-title":"Prevalence, definition and clinical manifestations of polycystic ovary syndrome","volume":"53","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.dsx.2018.12.020_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF03345554","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"29","author":"Essah","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.dsx.2018.12.020_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2018.12.020_bib7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2174\/1567201812666150120163025","article-title":"Excess metabolic and cardiovascular risk is not manifested in all phenotypes of polycystic ovary syndrome: implications for diagnosis and treatment","volume":"13","author":"Daskalopoulos","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.dsx.2018.12.020_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.dld.2013.09.018","article-title":"Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: chance tetrad or association by necessity?","volume":"46","author":"Nascimbeni","year":"2014","journal-title":"Dig. Liver Dis"},{"key":"10.1016\/j.dsx.2018.12.020_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of histological scoring system for non-alcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2 Suppl 1","key":"10.1016\/j.dsx.2018.12.020_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2018.12.020_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2011.04145.x","article-title":"The epidemiology, pathogenesis and histopathology of fatty liver disease","volume":"61","author":"Levene","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.dsx.2018.12.020_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2018.12.020_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dsx.2018.12.020_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpag.2011.03.002","article-title":"Prevalence of polycystic ovarian syndrome in Indian adolescentes","volume":"24","author":"Nidhi","year":"2011","journal-title":"J\u00a0Pediatr Adolesc Gynaecol"},{"key":"10.1016\/j.dsx.2018.12.020_bib15","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"Chen","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.12.020_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.dsx.2018.12.020_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/jc.2010-1608","article-title":"Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome","volume":"96","author":"Ma","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.12.020_bib18","first-page":"725","article-title":"The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS","volume":"11","author":"Qu","year":"2013","journal-title":"Iran J Reproductive Med"},{"key":"10.1016\/j.dsx.2018.12.020_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.dsx.2018.12.020_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J\u00a0Hum Reprod Sci"},{"issue":"8","key":"10.1016\/j.dsx.2018.12.020_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.18410\/jebmh\/2014\/133","article-title":"Incidence of non-alcoholic hepatic fatty infiltration in women with polycystic ovary syndrome","volume":"1","author":"Srinivas Prasad","year":"2014","journal-title":"Journal of Evidence Based Medicine and Healthcare"},{"key":"10.1016\/j.dsx.2018.12.020_bib22","first-page":"539","article-title":"Diagnosis of fatty liver disease: is biopsy necessary?","volume":"15","author":"Joy","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2018.12.020_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic fatty liver disease: a review and update","volume":"55","author":"Lewis","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dsx.2018.12.020_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2018.12.020_bib25","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/humrep\/dev195","article-title":"Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features","volume":"30","author":"Daan","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.dsx.2018.12.020_bib26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.dsx.2018.12.020_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dsx.2018.12.020_bib28","first-page":"117","article-title":"Liver affection in polycystic ovary syndrome (PCOS)","volume":"80","author":"Faisal","year":"2012","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.dsx.2018.12.020_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/ijpvm.IJPVM_305_16","article-title":"Nonalcoholic fatty liver disease in a sample of Iranian women with polycystic ovary syndrome","volume":"8","author":"Mehrabian","year":"2017","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.dsx.2018.12.020_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4158\/EP.11.5.319","article-title":"Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings","volume":"11","author":"Brown","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.dsx.2018.12.020_bib31","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.dsx.2018.12.020_bib32","article-title":"The usefulness of homeostatic measurement assessment-insulin resistance (HOMA-IR) for detection of glucose intolerance in Thai women of reproductive age with polycystic ovary syndrome","author":"Wongwananuruk","year":"2012","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.dsx.2018.12.020_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12020-014-0182-5","article-title":"Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria","volume":"47","author":"Alebic","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.dsx.2018.12.020_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.dsx.2018.12.020_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.dsx.2018.12.020_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/EP.2014.0058","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism","volume":"65","author":"Bohdanowicz-Pawlak","year":"2014","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.dsx.2018.12.020_bib37","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/en.2006-0879","article-title":"Regulation of adenosine 5\u2019, monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state","volume":"147","author":"McInnes","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.12.020_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2013.04.001","article-title":"Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice","volume":"138","author":"Kanaya","year":"2013","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.dsx.2018.12.020_bib39","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.18632\/oncotarget.24477","article-title":"Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.dsx.2018.12.020_bib40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.dsx.2018.12.020_bib41","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-16-1063","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur J Endocrinol"}],"updated-by":[{"DOI":"10.1016\/j.dsx.2020.12.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T02:12:20Z","timestamp":1606011140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118305952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402118305952"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.12.020","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.dsx.2020.12.009","asserted-by":"object"}]},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}